-
公开(公告)号：US20210038695A1
公开(公告)日：2021-02-11
申请号：US17081538
申请日：2020-10-27
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US20200376085A1
公开(公告)日：2020-12-03
申请号：US16999938
申请日：2020-08-21
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US20200164043A1
公开(公告)日：2020-05-28
申请号：US16778143
申请日：2020-01-31
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US20200147182A1
公开(公告)日：2020-05-14
申请号：US16732545
申请日：2020-01-02
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US20190275113A1
公开(公告)日：2019-09-12
申请号：US16420296
申请日：2019-05-23
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US10080781B2
公开(公告)日：2018-09-25
申请号：US15286362
申请日：2016-10-05
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US09987334B2
公开(公告)日：2018-06-05
申请号：US15285618
申请日：2016-10-05
CPC分类号： A61K38/26 , A61B5/4222 , A61K9/0019
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US09981015B2
公开(公告)日：2018-05-29
申请号：US15286171
申请日：2016-10-05
CPC分类号： A61K38/26 , A61B5/4222 , A61K9/0019
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US09603902B2
公开(公告)日：2017-03-28
申请号：US15286171
申请日：2016-10-05
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
公开(公告)号：US09597373B2
公开(公告)日：2017-03-21
申请号：US15285855
申请日：2016-10-05
摘要： Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
-
-
-
-
-
-
-
-
-
搜索结果
62 条记录 (耗时 0.024 秒)
